The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

Cell

Volumn 63, Issue 6, 1990, Pages 1129-1136

  Scheffner, Martin ^a   Werness, Bruce A ^a   Huibregtse, Jon M ^a   Levine, Arnold J ^b   Howley, Peter M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ARTICLE; PRIORITY JOURNAL; PROTEIN DEGRADATION; WART VIRUS;

ANTIGENS, POLYOMAVIRUS TRANSFORMING; BLOTTING, WESTERN; ENDOPEPTIDASES; HUMAN; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS; PROTEIN BINDING; PROTEIN P53; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSCRIPTION, GENETIC; TRANSLATION, GENETIC; UBIQUITINS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; TUMOR VIRUS;

EID: 0025639158     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(90)90409-8     Document Type: Article

References (54)

1. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas
2. Suppression of human colorectal carcinoma cell growth by wild-type p53
3. Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells
4. How are substrates recognized by the ubiquitin-mediated proteolytic system?
5. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
6. Heterogeneity of the human papillomavirus group
7. The human papillomavirus-16 E7 oncoprotein is able to bind the retinoblastoma gene product
8. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells
9. Meth A fibrosarcoma cells express two transforming mutant p53 species
10. Wild-type p53 can inhibit oncogene-mediated focus formation
11. Rb and a second cellular protein, p120
12. Presence of a potent transcription activating sequence in the p53 protein
13. Prediction of similar transforming regions in simian virus 40 large T, adenovirus E1A, and myc oncoproteins
14. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life
15. The p53 proto-oncogene can act as a suppressor of transformation
16. Inducible and constitutive enhancer domains in the noncoding region of human papillomavirus type 18
17. The immunochemical detection and quantitation of intracellular ubiquitin-protein conjugates
18. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes
19. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation
20. Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53
21. Cis-trans recognition and subunit-specific degradation of short-lived proteins
22. Immortalization of primary rat cells by human papillomavirus type 16 subgenomic DNA fragments controlled by the SV40 promoter
23. Transcriptional activation by the papillomavirus E6 zinc finger oncoprotein
24. T antigen is bound to a host protein in SV40-transformed cells
25. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
26. Analysis of human p53 proteins and mRNA levels in normal and transformed cells
27. Wild type human p53 is antiproliferative in SV40-transformed hamster cells
28. Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus
29. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes
30. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product
31. Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells
32. Cooperation between gene encoding p53 tumor antigen and ras in cellular transformation
33. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to adenovirus E1A
34. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene
35. Two distinct mechanisms regulate the levels of a cellular tumor antigen
36. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene
37. Transforming collaborations between ras and nuclear oncogenes
38. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells
39. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
40. Transcription of human papillomavirus-type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein
41. Comparison of the in vitro transforming activities of human papillomavirus types
42. p53: a frequent target for genetic abnormalities in lung cancer
43. Identification of a transforming gene of human papillomavirus type 16
44. Allelotype of colorectal carcinomas
45. The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene
46. Transformation of rat 3Y1 cells by human papillomavirus type-18 DNA
47. Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7
48. Association of human papillomavirus types 16 and 18 E6 proteins with p53
49. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product
50. Cellular targets for transformation by the adenovirus E1A proteins
51. Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene
52. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines
53. Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells
54. The role of papillomaviruses in human anogenital cancer